DDR1 and neoplasm: Both genetic and pharmacological inhibition of DDR1 disrupts this complex, enhancing ferroptosis, increasing tumor immunogenicity, and promoting CD8+ T cell infiltration, with the amplification of the antitumor efficacy of carbon ion radiotherapy [56].